Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Pharma channel feed
Novo petitions FDA over Victoza compounding as first generic wins approval
4 months ago
FDA+
GSK’s Nucala bags another China approval, but biggest test yet to come
4 months ago
R&D
Biopharma to raise more than 1,000 drug prices in 2025, advisory firm predicts
4 months ago
Regeneron buys London-based ocular biotech
4 months ago
Startups
Deals
FDA approves subcutaneous version of Bristol Myers' Opdivo
5 months ago
FDA+
BioNTech settles with NIH, UPenn in Covid vaccine disputes and will pay royalties
5 months ago
Coronavirus
Law
Federal appeals court says Teva must delist Orange Book inhaler patents
5 months ago
FDA+
Law
CMS explains what went into its first round of drug price negotiations
5 months ago
Law
Viatris' India-based manufacturing site blocked from shipping 11 generic drugs to US
5 months ago
FDA+
Sumitomo’s overactive bladder drug adds another indication
5 months ago
FDA+
FDA approves Lilly's Zepbound for sleep apnea, likely cracking open Medicare market
5 months ago
FDA+
Novo Nordisk’s once-daily hemophilia drug Alhemo approved in US
5 months ago
FDA+
Vertex gets 'vanza triple' approval and Trikafta expansion — with boxed warnings
5 months ago
FDA+
PBM reform unlikely to attach to short-term spending bill as shutdown looms
5 months ago
FDA+
Accelerated approval brings Pfizer's BRAF inhibitor to first-line patients
5 months ago
FDA+
Rhythm receives expanded approval for genetic obesity drug
5 months ago
FDA+
Xcovery nabs first FDA approval for lung cancer drug
5 months ago
FDA+
Mesoblast wins long-awaited approval for cell therapy
5 months ago
Cell/Gene Tx
FDA+
Payers generally meet drug price watchdog's 'fair access' standards, report says
5 months ago
FDA+
Regeneron forges ahead in factor XI despite field’s mixed results
5 months ago
R&D
In blow to compounders, FDA reaffirms tirzepatide shortage is over
5 months ago
Health Tech
The Endpoints 2024 winners and losers list: Who was up and who was down in biopharma
5 months ago
Special
US spent $450B on drugs last year, CMS says, with new obesity and diabetes drugs adding to total
5 months ago
FDA+
Novartis, AbbVie and PhRMA secure 340B court win in West Virginia
5 months ago
Law
First page
Previous page
19
20
21
22
23
24
25
Next page
Last page
Confirm Profile
Full Name
Email
Company
Job Title
{@!--CONSENT--!@}
Submit